Abstract:Fanconi anemia (FA) is a disease of genomic instability and cancer. In addition to DNA damage repair, FA pathway proteins are now known to be critical for maintaining faithful chromosome segregation during mitosis. While impaired DNA damage repair has been studied extensively in FA-associated carcinogenesis in vivo, the oncogenic contribution of mitotic abnormalities secondary to FA pathway deficiency remains incompletely understood. To examine the role of mitotic dysregulation in FA pathway deficient malignancies, we genetically exacerbated the baseline mitotic defect in Fancc-/- mice by introducing heterozygosity of the key spindle assembly checkpoint regulator Mad2. Fancc-/-;Mad2+/- mice were viable, but died from acute myeloid leukemia (AML), thus recapitulating the high risk of myeloid malignancies in FA patients better than Fancc-/-mice. We utilized hematopoietic stem cell transplantation to propagate Fancc-/-; Mad2+/- AML in irradiated healthy mice to model FANCC-deficient AMLs arising in the non-FA population. Compared to cells from Fancc-/- mice, those from Fancc-/-;Mad2+/- mice demonstrated an increase in mitotic errors but equivalent DNA cross-linker hypersensitivity, indicating that the cancer phenotype of Fancc-/-;Mad2+/- mice results from error-prone cell division and not exacerbation of the DNA damage repair defect. We found that FANCC enhances targeting of endogenous MAD2 to prometaphase kinetochores, suggesting a mechanism for how FANCC-dependent regulation of the spindle assembly checkpoint prevents chromosome mis-segregation. Whole-exome sequencing revealed similarities between human FA-associated myelodysplastic syndrome (MDS)/AML and the AML that developed in Fancc-/-; Mad2+/- mice. Together, these data illuminate the role of mitotic dysregulation in FA-pathway deficient malignancies in vivo, show how FANCC adjusts the spindle assembly checkpoint rheostat by regulating MAD2 kinetochore targeting in cell cycle-dependent manner, and establish two new mouse models for preclinical studies of AML.

MHF1-MHF2, a Histone-Fold-containing Protein Complex, Participates in the Fanconi Anemia Pathway Via FANCM.

Structural Insights into the Function of FANCM‐mediated Complexes

The structure of the FANCM–MHF complex reveals physical features for functional assembly

The histone-fold complex MHF is remodeled by FANCM to recognize branched DNA and protect genome stability

The MHF complex senses branched DNA by binding a pair of crossover DNA duplexes

FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair.

Structural Peculiarities of the (MHF1–MHF2)4 Octamer Provide a Long DNA Binding Patch to Anchor the MHF–FANCM Complex to Chromatin: A Solution SAXS Study

A FancD2-monoubiquitin Fusion Reveals Hidden Functions of Fanconi Anemia Core Complex in DNA Repair.

Rad5-dependent DNA Repair Functions of the Saccharomyces Cerevisiae FANCM Protein Homolog Mph1.

A Complex Involved in the Dna Damage Response Network of Fanconi Anemia and Breast Cancer

The Fanconi Anemia Core Complex Associates with Chromatin During S Phase.

Mechanism of structure-specific DNA binding by the FANCM branchpoint translocase

Fan1 Acts with Fanci-Fancd2 to Promote Dna Interstrand Cross-Link Repair

FANCM regulates repair pathway choice at stalled replication forks

Differential Phosphorylation of FANCA and FANCG Determines Response of Fanconi Anemia Core Complex to DNA Damage and S Phase.

Structure analysis of FAAP24 reveals single-stranded DNA-binding activity and domain functions in DNA damage response

FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity

Histone H3K27 Methylation Modulates the Dynamics of FANCD2 on Chromatin to Facilitate NHEJ and Genome Stability

Interaction Between the Helicases Genetically Linked to Fanconi Anemia Group J and Bloom'S Syndrome

FANCJ is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts*

Mitotic Errors Promote Genomic Instability and Leukemia in a Novel Mouse Model of Fanconi Anemia